๐
NovoRapid
insulin aspart
Diabetes Mellitus
โ
Authorised
โ
No active alerts
This medicine has no ongoing shortages, safety letters or recalls.
What it's used for
NovoRapid is indicated for treatment of diabetes mellitus in adults, adolescents and children aged 1 year and above.
โ ๏ธ Patient safety
No
๐ Past alerts (2)
Official EMA page
https://www.ema.europa.eu/en/medicines/human/EPAR/novorapid